Home Topics Drug Discovery Flagship Pioneering Unveils ProFound Therapeutics to Target Previously Undiscovered Human Proteins

Ribosome as part of an biological cell constructing mRNA molecule - 3d illustration — Ribosome as part of an biological cell constructing messenger rna molecule - iStock / Getty Images Plus

Flagship Pioneering Unveils ProFound Therapeutics to Target Previously Undiscovered Human Proteins

The Cambridge-based company has received $75 million to enable drug discovery efforts aimed at thousands of new proteins and to build a robust R&D pipeline.

By Jonathan Grinstein, PhD

May 26, 2022

Ribosome as part of an biological cell constructing messenger rna molecule - iStock / Getty Images Plus

Flagship Pioneering, a venture capital firm investing in biomedical platform innovation, today announced ProFound Therapeutics, a new company that has identified thousands of previously unmapped human proteins, opening the door to a slew of novel therapeutic targets and therapies. The groundbreaking ProFoundry Platform™, which was founded at Flagship Labs in 2020, has spotted unique proteins, remapping the human genome landscape . . .